In the ongoing battle against tick-borne diseases in dogs, a groundbreaking study has brought hope to pet owners worldwide. The research focused on Babesia canis, a dangerous pathogen that poses a growing threat to canine health. The spotlight of this study was on Simparica Trio® (Zoetis), a treatment that combines sarolaner, moxidectin, and pyrantel in a powerful formula designed to prevent the transmission of B. canis.